COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,287 Articles (22,759 medRxiv, 8,528 bioRxiv)

Most recent first Previous |  Page 132: Articles 1311-1320  | Next

Defining a highly conserved B cell epitope in the receptor binding motif of SARS-CoV-2 spike glycoprotein
Malladi, S. K., Jaiswal, D., Ying, B., Alsoussi, W., Darling, T., Dadonaite, B., Civljak, A., Horvath, S., Zhou, J., Kim, W., Turner, J., Schmitz, A., Han, F., Scheaffer, S., Farnsworth, C., Nachbagauer, R., Nestorova, B., Chalkias, S., Klebert, M., Edwards, D., Paris, R., Strnad, B., Middleton, W., OHalloran, J., Presti, R., Bloom, J. D., Boon, A. C. M., Diamond, M. S., Bajic, G., Ellebedy, A. H.
10.1101/2024.12.06.625234 — Posted: 2024-12-09
Cost-utility analysis of COVID-19 vaccination strategies for endemic SARS-CoV-2 circulation in Canada
Miranda, R. N., Simmons, A. E., Li, M. W. Z., Gebretekle, G. B., Xi, M., Salvadori, M. I., Warshawsky, B., Wong, E., Ximenes, R., Andrew, M. K., Sander, B., Singh, D., Wilson, S., Tunis, M., Tuite, A. R.
10.1101/2024.12.06.24318620 — Posted: 2024-12-08
Effect of background therapy with Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents on COVID-19 outcomes
Miele, L., Chu, S., Hillegass, W., Jurkovitz, C., Beasley, W., Chen, D., Anzalone, J., Fort, D., Kirwan, J., Melancon, B., Hodder, S., Horswell, R.
10.1101/2024.12.07.24318645 — Posted: 2024-12-08
Capture of fusion-intermediate conformations of SARS-CoV-2 spike requires receptor binding and cleavage at either the S1/S2 or S2' site
Lusvarghi, S., Vassell, R., Williams, B., Baha, H., Neerukonda, S. N., Weiss, C. D.
10.1101/2024.12.05.627124 — Posted: 2024-12-06
Impacts of the COVID-19 pandemic on antibiotic use and resistance in hospitals: a retrospective ecological analysis of French national surveillance data over 2019-2022
Layan, M., Smith, D. R. M., Kerneis, S., Simon, L., Dumartin, C., Dugravot, L., Jouzeau, A., Maugat, S., Gambotti, L., Watier, L., Opatowski, L., Temime, L.
10.1101/2024.12.04.24317990 — Posted: 2024-12-06
Willingness to pay for COVID-19 vaccine and its correlates: A cross-sectional survey in Bangladesh
Hossain, M. B., Alam, M. Z., Islam, M. S., Sultan, S., Faysal, M. M., Rima, S., Hossain, M. A., Mamun, A. A., Mamun, A.- A.-
10.1101/2024.12.03.24318442 — Posted: 2024-12-06
SARS-CoV-2 predation of Golgi-bound PI4P primes the massive activation of the DNA Damage Response kinase ATM in the cytoplasm
Rebendenne, A., Soulet, C., Valadao, A. L. C., Bonaventure, B., McKellar, J., Moncorge, O., Goujon, C., Moriel-Carretero, M.
10.1101/2024.12.05.626967 — Posted: 2024-12-06
Exploring clinical characteristics of COVID-19 in children and adolescents using a machine-learning approach
Fiandrino, S., Dona, D., Giaquinto, C., Poletti, P., Tira, M. D., Paolotti, D., Di Chiara, C.
10.1101/2024.12.04.24318465 — Posted: 2024-12-06
A Phase II/III, Randomized, double-blind, placebo-controlled trial to evaluate Immunogenicity and Safety of the Gam-COVID-Vac combined vector vaccine in the prophylactic Treatment for SARS-CoV-2 infection in the United Arab Emirates
AlHammadi, A. A., Alzaabi, A. H., Choker, H. B., Ibrahim, A. A., Ishaq, A. B., Mahboub, A. E., Al Dhaheri, R. S., Alzaabi, M. N., Collyns, T. A., ElGhazali, G., Weber, S., al-Ramadi, B. K.
10.1101/2024.11.29.24318199 — Posted: 2024-12-05
Weighted analysis of symptom profile by vaccination status in positive SARS-CoV-2 cases: observational study in Sao Goncalo, Brazil
das Chagas, R. R., Freitas, H. R., Cardozo, S. V.
10.1101/2024.12.03.24318348 — Posted: 2024-12-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).